The Life Sciences Discovery Fund (LSDF) today announced nearly $450,000 in awards to three Washington non-profit organizations to foster commercial translation of new health and health-care products.
Two of the grants focus on infectious disease. Dr. Philip Fleckman at the University of Washington will assess the effectiveness of a novel material for reducing infections associated with kidney dialysis catheters. Dr. Timothy Rose at Seattle Children's Research Institute will develop a test to detect common respiratory infections in outpatient or point-of-care settings.
To read the full, original article click on this link: Washington's Life Sciences Discovery Fund awards commercialization grants
